Filter
179
Filtered Results: 179
Text search:
delamanid
Featured
Recommendations
30
New Publications
40
Language
Document type
No document type
96
Guidelines
35
Studies & Reports
19
Manuals
14
Training Material
6
Fact sheets
3
Situation Updates
2
Strategic & Response Plan
2
Brochures
1
Infographics
1
Countries / Regions
Western and Central Europe
15
Eastern Europe
11
Argentina
5
South Africa
5
Latin America and the Carribbean
4
Germany
4
Bolivia
3
India
3
Nigeria
2
Malawi
2
Global
2
Asia
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Russia
2
Ethiopia
2
Tajikistan
1
Switzerland
1
Colombia
1
Ukraine
1
Turkey
1
Estonia
1
Burkina Faso
1
Peru
1
Guinea
1
Guinea-Bissau
1
Venezuela
1
Congo, Democratic Republic of
1
West and Central Africa
1
Paraguay
1
East and Southern Africa
1
Brazil
1
Namibia
1
Romania
1
Georgia
1
Central African Republic
1
Chad
1
Botswana
1
Zambia
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
42
Countries
39
Public Health
5
Pharmacy & Technologies
3
Women & Child Health
2
Key Resources
1
Toolboxes
TB
120
COVID-19
10
HIV
9
Caregiver
9
Pharmacy
6
Mental Health
3
Refugee
3
Global Health Education
3
AMR
3
Ebola
2
Conflict
2
Rapid Response
1
Disability
1
Social Ethics
1
Planetary Health
1
NTDs
1
Polio
1
Eine Leitlinie zur Diagnostik und Therapie, einschließlich Chemoprävention und -prophylaxe des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose e.V. im Auftrag der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.
Tuberculosis Guideline for Adults
Guideline for Diagnosis...
Epidemiologisches Bulletin; 14. März 2016 Nr. 10/11 ;DOI 10.17886/EpiBull-2016-014
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
Outstanding child and adolescent TB priorities include the need to: find the missing children with active TB and link them to TB care; prevent TB in children who are in contact with infectious TB cases (through implementation of active contact investigation and provision of preventive treatment); an...
The update of the ESTC was conducted as a joint endeavour with ERS, consulting experts from international societies and organisations, national TB programmes, civil society and affected communities. The second edition of the ESTC includes 21 standards in the areas of diagnosis, treatment, HIV and co...
European Union Standards for Tuberculosis Care 2017 Estonian Version
European Union Standards for Tuberculosis Care 2017 Update (Romanian Version)
This document aims to provide concrete, pragmatic guidance for how TB modelling and related technical assistance is undertaken to support country decision-making. The target audience for this document are the participants and stakeholders in country-level TB modelling efforts, including the individu...
